2ⁿᵈ Edition of the Cancer R&D World Conference 2026

Scientific Sessions

Ovarian Cancer

Ovarian cancer develops when cancerous cells grow in the ovaries; because early signs can occasionally be vague, the disease is frequently discovered at an advanced stage. The significant challenge presented by this late-stage diagnosis is exacerbated by the scarcity of available treatments and the high incidence of recurrence after initial therapy. To overcome these obstacles, we must improve public knowledge of the warning signs and symptoms of ovarian cancer and advance diagnostic methods to facilitate early detection.

Related Sessions

Current Landscape and Future Directions of Oncology Research
Oncogenic Signaling Pathways and Therapeutic Targets
Emerging Biomarkers for Cancer Detection and Prognosis
Cancer Prevention and Early Detection Strategies
Immuno-Oncology and Cell-Based Therapies
Innovations in Immuno-Oncology
Cytokine Modulation and Immune Adjuvants in Cancer Immunotherapy
Cancer Vaccines
CAR-T Cell Therapy: Clinical Progress and Challenges
Next-Generation Cell and Gene Therapies in Oncology
Liquid Biopsy and Circulating Tumor DNA (ctDNA) Diagnostics
Companion Diagnostics
Artificial Intelligence and Machine Learning in Precision Oncology
Next-Generation Targeted Therapies: KRAS, HER2, BRAF, and NRAS
Overcoming Drug Resistance: Mechanisms and Solutions
Oncology Pipeline
Trends in Antibody–Drug Conjugates (ADCs)
Launch of Novel mAb Products for Cancer Therapy